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Abstract:  29 
During the peri-ovulatory period the cervix relaxes in response to changes in circulating 30 
concentrations of reproductive hormones.  The present study investigated the role of 31 
gonadotrophins in cervical function by examining the expression of cyclooxygenase-2 (COX2) 32 
and COX2 mRNA and the concentration of hyaluronan (HA) in the cervix, following intra-33 
cervical treatment with either follicle stimulating hormone (FSH) or luteinizing hormone (LH).  34 
Eighteen ewes were assigned to 4 groups.  They were then treated with commercial intravaginal 35 
progestagen sponges and equine chorionic gonadotrophin (eCG) to synchronize their oestrous 36 
cycles.  Intra-cervical treatments were given 24h after removal of the sponges as follows: Group 37 
1: FSH, 2 mg; Group 2: LH, 2 mg; Group 3: vehicle and Group 4: control.  Cervices were 38 
collected 54h after sponge removal and then divided into 3 regions.  The expression of COX2 39 
and COX2 mRNA was determined by immunohistochemistry and in situ hybridization and those 40 
of HA by ELISA. The levels of expression of COX2, COX2 mRNA and HA were compared in 6 41 
tissue layers (luminal epithelium, sub-epithelial stroma, circular, longitudinal and transverse 42 
muscle and serosa) and in 3 cervical regions (vaginal, mid and uterine).  The results showed that 43 
both FSH and LH significantly increased the levels the COX2 mRNA and COX2 in the cervix 44 
but, the effects of the gonadotrophins were selective.  The effects of both FSH and LH were most 45 
evident at the vaginal end of the cervix and least at the uterine end of the cervix.  Furthermore 46 
their effects were confined to the stroma and smooth muscle layers of the cervix in the case of 47 
FSH and to smooth muscle only in the case of LH.  Neither FSH nor LH affected the 48 
concentration of HA in the cervix although FSH but not LH reduced the concentration of HA in 49 
cervical mucus.  These findings suggest that the gonadotrophins regulate the expression of 50 
COX2 in the cervix and that they may have a role facilitating relaxation of the cervix during 51 
oestrus in the ewe.  52 
 53 
Key words:  Sheep, cervix, hyaluronan, COX2, gonadotrophins, epithelium, stroma, smooth 54 
muscle 55 
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Introduction 57 
One of the main purposes of artificial insemination in sheep breeding is to increase the rate of 58 
genetic improvement for a particular trait or group of traits. However, conventional cervical 59 
insemination in sheep gives poor fertility particularly if the semen used has been frozen and 60 
thawed (F-T), mainly because of the unusual anatomy of the sheep cervix.  The ovine cervix is a 61 
long, fibrous and convoluted tubular organ that prevents easy passage of an insemination pipette 62 
along the cervical lumen [1, 2].  Consequently, semen is normally deposited at the entrance to 63 
the cervix and the spermatozoa have to traverse the cervix to enter the uterus and eventually, the 64 
site of fertilization in the oviducts. The reduced motility of F-T semen compromises its ability to 65 
transit of the cervix [3].  Consequently, a practical, low cost and effective technique for 66 
intrauterine insemination would be a valuable aid to sheep breeding. 67 
 68 
There is some natural relaxation of the cervix at oestrus [4] that is probably regulated by the peri-69 
ovulatory changes in reproductive hormones [5]. The cervix contains receptors for oestradiol, 70 
progesterone, oxytocin [6] as well as those for luteinizing hormone (LH) and follicle stimulating 71 
hormone (FSH) [7-13] suggesting that the gonadotrophins may have a functional role in cervical 72 
physiology at oestrus. 73 
 74 
There is good evidence indicating that cervical relaxation at oestrus is mediated by Prostaglandin 75 
E2 (PGE2) [4, 14-17].  The peri-ovulatory changes in reproductive hormones are associated with 76 
increased levels of cervical cyclooxygenase-2 (COX2) also known as prostaglandin 77 
endoperoxide synthase and the increased cervical synthesis of PGE2 [16, 18]. Similarly in the 78 
cow, cervical relaxation during oestrus is mediated by a local increase in COX2 and a subsequent 79 
increase in the production of PGE2 by the cervix [19].  Prostaglandin E2 separates cervical 80 
collagen fibres reducing the tensile strength of the cervix [15] and allowing the cervical canal to 81 
dilate. Naturally occurring cervical relaxation at oestrus is probably the result of complex 82 
interactions among reproductive hormones acting on the cervix.  An increase in the levels of 83 
receptors for oestradiol and oxytocin during the peri-ovulatory period is thought to mediate 84 
increased synthesis of PGE2 [19] leading to remodeling of the extracellular matrix [20, 21] 85 
characterized by a loosening of the collagen bundles [22] and associated increases in the cervical 86 
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concentrations of glycosaminoglycans (GAGs) especially hyaluronan (HA). These PGE2 induced 87 
changes are partially responsible for cervical relaxation as demonstrated by the ability of an 88 
intra-cervical application of HA to increase cervical penetrability in oestrus ewes [23] and does  89 
[24]. 90 
 91 
Gonadotrophin receptors have been identified in the cervix of the cow and the ewe and both FSH 92 
receptor (FSHR) and its mRNA are highest during pro-oestrus and oestrus  [8] at a time when 93 
circulating FSH is also high [25]. Similarly, LHR and its mRNA are also present in the cervix of 94 
cows [19, 25]. The presence of LH receptor (LHR) in cervical tissue has been reported in women 95 
[26] and furthermore intra-cervical human chorionic gonadotrophin (hCG) increased the levels 96 
of cAMP and COX2 in the human cervix [26].  The role of gonadotrophins in cervical relaxation 97 
although implied by the presence of their receptors and some downstream mediators in the cervix 98 
remains unclear. 99 
 100 
There is very little data on the action of gonadotrophins in the ovine cervix although in a 101 
previous study [13] we showed that the local application of FSH and/or an analogue of PGE 102 
(Misoprostol) enhanced the penetrability of the cervix [4, 13]. These data collectively suggest 103 
that the intra-cervical application of gonadotrophins may enhance relaxation of the cervix to 104 
facilitate intrauterine insemination.  105 
 106 
Consequently we set out to define in greater detail, the actions of FSH and LH on the ovine 107 
cervix during the peri-ovulatory period of the oestrous cycle by studying the effects of intra-108 
cervical LH and FSH on the intra-cervical levels of COX2 protein and mRNA and the 109 
concentrations of HA in cervical tissue and cervical mucus. 110 
 111 
 112 
Materials and Methods 113 
Animals and their management 114 
In this study 18 adult Welsh Mountain ewes were divided randomly into two groups of 5 and two 115 
groups of 4 ewes. Due to the small number of animals a simple randomization method was 116 
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applied. Each ewe was assigned a unique number from 1 to 18. These numbers were then written 117 
on small pieces of papers and were thoroughly mixed in a bowl. Then without looking, 5 118 
numbers were picked up randomly for each of the group 1 (FSH) and group 2 (LH), and 4 119 
numbers for each of the group 3 (gum acacia vehicle ) and group 4 (no vehicle).  120 
 121 
The multiparous ewes were all healthy and cycling normally during last breading season. They 122 
had average (±SD) body condition score of 2.94 ±0.3 (2.5-3.5),  body weight of 36.9±3.0 (32 _ 123 
42) kg and age of 19.8±2.1 (17 - 25) months . The animals in different experimental groups did 124 
not vary in their body weight, body condition score, age or parity (Table 1).  Moreover, these 125 
ewes did not have any reproductive problems previously  126 
 127 
 During the experiment the animals were housed indoors, in groups, on straw bedding and were 128 
fed with a commercial concentrate diet ad libitum and with hay and water always available. All 129 
the experimental procedures with ewes were conducted with the approval of the ethics 130 
committee of the Royal Veterinary College, University of London and with authorization from 131 
the Home Office (United Kingdom) in compliance with the Animal (Scientific Procedures) Act, 132 
1986. 133 
 134 
Intra-cervical administration of FSH or LH  135 
The ewes were synchronized to a common day of oestrus using intra-vaginal sponges containing 136 
30 mg of fluorogestone acetate (Chronogest; Intervet UK Ltd, Northamptonshire, UK) for 12 137 
days. The experiment was conducted during the non-breeding season (March to April) therefore, 138 
ewes were injected intramuscularly with 500IU of equine chorionic gonadotrophin (eCG; 139 
Intervet UK Ltd., Buckinghamshire, UK), at the time of removal of sponges. Ovine FSH (2 mg 140 
Ovagen; ICPbio (UK) Limited, Wiltshire, UK) or ovine LH (2 mg, Sigma-Aldrich Chemie 141 
GmbH, Steinheim, Germany) was dissolved in 0.5 ml of a vehicle consisting of 50% gum acacia 142 
(Sigma-Aldrich Chemie GmbH, Steinheim, Germany) in normal saline.  The ewes were 143 
restrained in a yoke fitted with sidebars to minimize lateral and forward movements with the 144 
hindquarters of the ewe raised about 4 inches.  A 1 ml Eppendorf (Eppendorf AG, Hamburg, 145 
Germany) pipette fitted with a 10 cm extension consisting of 3 X 1 ml pipette tips glued together 146 
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was used for intra-cervical administration.  The tip of the extension pipette was blunted, by 147 
cutting off about 0.2 mm of the tip, the extension pipette was then sterilised.   The perineum was 148 
wiped clean with a disinfectant wipe and a duckbill vaginal speculum introduced into the vagina 149 
so that the external cervical opening could be seen in the light of the speculum lamp.  The pipette 150 
tip was inserted about 1-2 cm into the cervix and the 0.5 ml bolus deposited in 80% of ewes, 151 
when this was not possible and the FSH or LH was placed at the os cervix.  In a series of 152 
preliminary tests we established the maximum volume (0.5ml) and viscosity of vehicle required 153 
to ensure that the bolus did not leak from the cervical canal. The intra-cervical treatments were 154 
applied 24 h after removal of the sponges as follows: Group 1, FSH (2 mg; n = 5); Group 2, LH 155 
(2 mg; n = 5); Group 3, gum acacia vehicle (n = 4) and Group 4, no vehicle (the intra-cervical 156 
procedure was carried out but no vehicle was deposited in the cervix; n = 4). 157 
 158 
Collection of cervical mucus and cervical tissue 159 
Cervical mucus was collected at 48h and 54h after sponge removal, from the anterior vagina or 160 
fornix using a duckbill vaginal speculum (attached with a penlight) pressed gently to the floor of 161 
the vulva and with a downwards movement of the speculum handle thus allowing the mucus to 162 
drain through the speculum into a collecting tube. The mucus was stored at -80 C.  Ewes were 163 
killed 54h after removal of sponges (i.e. 30h after treatment) with a captive bolt pistol followed 164 
by exsanguination.  The reproductive tract was removed immediately after death and kept on ice.  165 
All unwanted tissue was trimmed from the cervix which was then divided into 3 approximately 166 
equal transverse segments [10, 27] representing the uterine, middle, and vaginal regions of the 167 
cervix. The segments were fixed in neutral-buffered formalin (BDH, VWR International Ltd., 168 
Leicestershire, UK) for 24h, and then stored in 70% ethanol.  Fixed tissues were embedded in 169 
paraffin wax; sections were cut at 7µm on a rotary microtome and mounted onto Superfrost Plus 170 
slides (BDH, VWR International Ltd., Leicestershire, UK). 171 
 172 
The determination of COX2 mRNA 173 
The levels of mRNA for COX2 were determined by in situ hybridization (ISH) using 174 
digoxigenin-11-UTP labeled sense and antisense riboprobes synthesized by Dr. Claire Kershaw, 175 
The Royal Veterinary College University of London [5, 27].  Eight sections were examined from 176 
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each of the three regions of the cervix of each animal, using 4 sections for the sense riboprobe 177 
and 4 sections for the antisense riboprobe. Sense and antisense riboprobes were used on different 178 
slides.  179 
 180 
The determination of COX2 protein 181 
The procedure for the immunohistochemical localization was the same as described for our 182 
laboratory [23, 28-30]. Immunoperoxidase staining was used to determine the level of COX2 183 
using a polyclonal antibody (H-62 from Santa Cruz Biotechnology Inc., Santa Cruz, California, 184 
USA).  Sections from each region of the cervix from each animal were examined in triplicate for 185 
both positive staining and negative controls. The binding site of the enzyme was stained with 186 
diaminobenzidine-based peroxidase substrate (ImmPAC™ DAB, Vector Laboratory Ltd, 187 
Cambridgeshire, England), then counterstained with hematoxylin (Hematoxylin QS, H-3404, 188 
Vector Laboratory Ltd, Cambridgeshire, England). Negative controls were examined in the same 189 
manner but substituting the primary antibody with the non-immune rabbit IgG (Santa Cruz 190 
Biotechnology, Santa Cruz, California, USA) at an equivalent concentration.  191 
 192 
Quantification of in-situ hybridization and immunohistochemistry staining 193 
The levels of both mRNA and protein for COX2 were assessed blind in six tissue layers of the 194 
cervix, namely the luminal epithelium, sub-epithelial stroma, circular smooth muscle, 195 
longitudinal smooth muscle, transverse smooth muscle and the outer serosa as described in our 196 
previous studies [10, 13, 29, 30]. No positive staining for either COX2 or its mRNA was 197 
detected in the serosa. The staining in the other five cell layers in each region of the cervix was 198 
scored for both the percentage of cells stained and the intensity of staining as described and 199 
validated in previous publications from our laboratory [10, 16, 17, 27, 29-31]. 200 
 201 
Hyaluronan  202 
(i) Papain extraction and digestion: The concentration of HA in cervical tissue was determined 203 
by ELISA following the extraction of total GAGs by papain digestion.  The extraction of GAGs 204 
was performed using frozen (-80 C) tissue [32]. Frozen cervical tissue was thawed slowly on 205 
wet ice and a transverse section of the tissue was cut and finely chopped using a sterile scalpel 206 
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blade. The papain buffer was prepared and pre-heated at 60C for 30 min before use, to activate 207 
the enzyme. The papain buffer contained 0.25 mg/mL papain (Roche Diagnostics GmbH, 208 
Mannheim, Germany) in 0.1M sodium acetate buffer, pH 5.8, (Sigma-Aldrich Chemie GmbH, 209 
Steinheim, Germany) containing 5 mM EDTA (Sigma-Aldrich Chemie GmbH, Steinheim, 210 
Germany) and 5 mM/L anhydrous cysteine hydrochloride (Sigma-Aldrich Chemie GmbH, 211 
Steinheim, Germany). The papain buffer (2 mL) was added to 300mg chopped tissue in a 15 mL 212 
Falcon tube which was then covered and sealed with Parafilm to prevent evaporation. The tissues 213 
were incubated at 60C for 16 to 18 h by which time the tissue was completely digested. The 214 
following day, 1 mL of the digested lysate was placed in a sterile 1.5 mL Eppendorf tube. Papain 215 
activity was halted by the addition of 10 µL of 0.5 M iodoacetic acid (Sigma-Aldrich Chemie 216 
GmbH, Steinheim, Germany) to 1mL of digested lysate. The tubes were mixed on a vortex mixer 217 
and then incubated at 37C for 30 min after which the tubes were centrifuged at 13,000 rpm for 218 
10 min. The supernatant was pipetted into a clean 1.5 mL Eppendorf  tube and then stored at -219 
20C. 220 
 221 
(ii) Hyaluronan ELISA: The digested tissue supernatant was assayed in duplicate by ELISA [33]. 222 
Nunc-Immuno MaxiSorpTM 96 well plates (VWR International Ltd., Lutterworth, Leicestershire, 223 
UK) were coated overnight at 37C with 100 µL/well of 25 µg/mL human umbilical cord HA 224 
(Sigma-Aldrich Chemie GmbH, Steinheim, Germany) in 20 mM sodium carbonate buffer pH 9.6 225 
(Sigma-Aldrich Chemie GmbH, Steinheim, Germany). The following day the coating solution 226 
was removed and the plate washed 3 times in PBS containing 0.1 % Tween 20 (PBS-Tween , 227 
BDH, VWR International Ltd., Lutterworth, Leicestershire, UK), then blocked with 100 µL of 228 
1% BSA in PBS-Tween for 1 h at 37C, and finally washed 3 more times in PBS-Tween. Serial 229 
dilutions of a HA standard  (human umbilical cord HA ;Sigma-Aldrich Chemie GmbH, 230 
Steinheim, Germany) were made up in PBS-Tween at concentrations of 5.0, 2.5, 1.25, 0.625, 231 
0.3125, 0.156, 0.078, 0.039, 0.0195 and 0.00976 µg/mL.  Supernatant samples were diluted 232 
1:1000 in 0.01M sodium acetate buffer to enable the concentration of HA to fall on the standard 233 
curve. Samples or standards (50 µL) were added to the wells in duplicate followed by 50 µL of 234 
0.33 µg/mL biotinylated hyaluronic acid binding protein (bHABP; Seikagaku America, 235 
Falmouth, Massachusetts, USA). The plates were incubated overnight at room temperature. 236 
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Blank wells containing 100 µL of PBS-Tween only were included in duplicate on each plate and 237 
used to zero the plate reader.  Maximum binding was determined in wells that contained 50 µL 238 
of PBS-Tween and 50 µL of bHABP.  Quality control samples made from pooled cervical 239 
supernatants were also assayed in duplicate on each plate to determine the inter-assay coefficient 240 
of variation. 241 
 242 
Next day, each plate was washed 3 times in PBS-Tween and 100 µL of the colour reagent 243 
Streptavidin-biotinylated horseradish peroxidase complex (Amersham Biosciences UK Ltd, 244 
Amersham, Buckinghamshire, UK) diluted 1:1000 in PBS-Tween, was added to all wells and the 245 
plate incubated for 30 min at 37C. After incubation the plate was washed 3 times with PBS-246 
Tween and 100 µL of ABTS  (2,2’-azino-bis-(3-ethylbenzthiazoline-6-sulphonic acid) 247 
diammonium salt) substrate was added to all wells to develop the colour.  The ABTS substrate 248 
was warmed to room temperature before addition to the wells. The plate was incubated at 37C 249 
for approximately 20 min by which time the optical density at 405nm (OD405) of the maximum 250 
binding wells reached approximately 1.5. The optical density was read immediately,  at OD405 251 
and the concentrations of hyaluronan were determined against the optical density of the 252 
standards. The limit of the sensitivity of the assay was 0.90 µg/mL. The intra-assay coefficient of 253 
variation was 8.60% and the inter-assay coefficient of variation was 18.60%. 254 
 255 
Cervical dry matter 256 
Frozen cervical tissue was thawed on wet ice and a small piece removed using a sterile scalpel 257 
blade. The piece was weighed, transferred to a dry air incubator at 60C and left overnight (20 258 
h).  Next day the dried cervical tissue was weighed and the percentage dry weight and the 259 
percentage water calculated. 260 
 261 
Statistical analysis 262 
The results are presented as means and standard error of the mean (S.E.M).  The effects of 263 
treatment, region and tissue layer were analyzed using a mixed model ANOVA.  Sheep were 264 
treated as subjects with cervical region and tissue layer as nested factors and hormonal treatment 265 
as a fixed factor.  Where it was appropriate, additional post-hoc tests comparing the effects of 266 
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treatment within either cervical region or cervical layer were made using the least significant 267 
difference (LSD) test.  The tests were carried out using SPSS for Windows (SPSS version 20.0; 268 
SPSS Inc., IBM Company Headquarters, Chicago, Illinois, USA).  Differences were considered 269 
statistically significant when P ≤ 0.05.  270 
 271 
 272 
Results 273 
Effects of FSH and LH on the Expression of Cervical COX2 mRNA and COX2 274 
The expression of COX2 mRNA in the cervix of ewes treated with intra-cervical FSH was 275 
significantly greater than those treated with vehicle (P = 0.003) or the untreated control group (P 276 
= 0.004; Figure 1).  Similarly, the expression of COX2 mRNA in the cervix of ewes treated with 277 
intra-cervical LH was significantly greater than those treated with vehicle (P = 0.007) or the 278 
untreated control group (P =0.006; Figure 1). There was no significant difference between the 279 
FSH and LH (P = 0.77) or between vehicle and untreated control groups (P = 0.95) 280 
 281 
The results for COX2 closely paralleled those for COX2 mRNA (Figure 1).  The expression of 282 
COX2 in the sheep cervix was increased by treatment for both the FSH and LH groups compared 283 
to the vehicle groups [FSH (P =0.006) and LH (P = 0.05)] groups and the untreated control 284 
groups FSH (P =0.05) and LH (P= 0.05). The expression of COX2 was not different between the 285 
vehicle and control (P = 0.70) groups nor between the FSH and LH groups (P = 0.29; Figure 1).  286 
 287 
Patterns of Expression of COX2 mRNA and COX2 in the Regions of the Cervix 288 
The pattern of expression of COX2 mRNA and COX2 in the regions of the cervix are shown in 289 
Figure 2.  The overall expression index of COX2 mRNA, irrespective of the treatment groups, 290 
was significantly different (P <0.001) among regions.  The expression of COX2 mRNA at the 291 
vaginal end (P <0.001) and the mid-cervix (P <0.001) were both significantly greater than the 292 
uterine end.  There was no difference between the vaginal end and the mid-cervix (P = 0.68).  293 
However, the expression of COX2 was not significantly different among the three regions of the 294 
cervix. 295 
 296 
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Effects of FSH and LH on the Expression of COX2 mRNA and COX2 in the Regions of the 297 
Cervix 298 
The effects of intra-cervical FSH and LH on the pattern of expression of both COX2 mRNA and 299 
COX2 in the three regions of the cervix are shown in Figure 3.  At the uterine end of the cervix, 300 
intra-cervical FSH increased the expression of COX2 compared to untreated control (P = 0.009) 301 
and vehicle treated control (P = 0.008) ewes but it had no effect on the expression of COX2 302 
mRNA.  Furthermore, in the mid-cervix FSH had no effect on the expression of either COX2 or 303 
its mRNA.  At the vaginal end of the cervix, FSH strongly increased the expression of both 304 
COX2 and its mRNA compared to untreated control (both P <0.001) and vehicle treated control 305 
(both P <0.001) ewes.  There was no effect of intracervical LH at the uterine end of the cervix or 306 
in the mid-cervix on the expression of either COX2 mRNA or COX2 protein itself. However, 307 
intra-cervical LH strongly increased the expression of both COX2 mRNA and COX2 at the 308 
vaginal end of the cervix compared to both untreated control (both P <0.001) and vehicle treated 309 
controls (both P <0.001) ewes 310 
.  311 
Patterns of expression of COX2 mRNA and COX2 in the Cellular Layers of the Cervix 312 
The pattern of expression of COX2 mRNA and COX2 in the five tissue layers of the cervix are 313 
shown in Figure 4.  There was no expression of either COX2 mRNA or COX2 itself in the outer 314 
serosal (sixth) layer of the cervix and these data are not presented.  The expression of both COX2 315 
and its mRNA were both significantly different (both P < 0.001) among the cellular layers of the 316 
cervix; expression in the three smooth muscle layers and the luminal epithelium were all 317 
significantly higher than in sub-epithelial stroma (all P < 0.001).  There were no significant 318 
differences among the muscle layers and the luminal epithelium.   319 
 320 
Effects of FSH and LH on Expression of COX2 mRNA and COX2 in the Cellular Layers of 321 
the Cervix 322 
The effects of intra-cervical FSH and LH on the pattern of expression of both COX2 mRNA and 323 
COX2 in the five cellular tissue layers of the cervix are shown in Figure 5.  There was no effect 324 
of intra-cervical FSH on the expression of COX2 mRNA in luminal epithelium compared to both 325 
untreated control (P = 0.20) and vehicle treated control (P = 0.13) ewes.  For COX2 itself there 326 
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was a significant effect of intra-cervical FSH in in luminal epithelium compared to untreated 327 
control (P = 0.004) ewes but not to vehicle untreated control (P = 0.10) ewes.  Intra cervical LH 328 
had no effect on the expression of COX2 or its mRNA in luminal epithelium compared to both 329 
untreated control (P = 0.20) and vehicle treated control (P = 0.13) ewes. In the sub-epithelial 330 
stroma, intra-cervical FSH increased the expression of both COX2 mRNA and COX2 compared 331 
to both untreated control (P = 0.004 and P = 0.006) and vehicle treated control (P = 0.01 and P = 332 
0.05) ewes.  However, intra-cervical LH had no effect on the expression of COX2 in the sub-333 
epithelial stroma, compared to either the untreated (P = 0.11) or vehicle treated control (P = 334 
0.45) groups although it COX2 mRNA was increased compared to untreated controls (P = 0.018) 335 
and approached significance (P = 0.055) when compared to vehicle treated controls.   Intra-336 
cervical FSH increased the expression of COX2 mRNA and COX itself in all three layers of 337 
smooth muscle compared to both untreated control (P = 0.003 & P = 0.008 - LM; P = 0.003 & P 338 
= 0.004 - CM; P = 0.04 & p =0.03- TM) and vehicle treated control (P = 0. 01 & P = 0.02 - LM; 339 
P = 0.004 & P = 0.01 - CM; P = 0.008 & P =0.05 - TM) ewes.  Intra-cervical LH increased the 340 
expression of COX2 mRNA and COX2 itself only in circular smooth muscle compared to the 341 
untreated control group (P = 0.002 & P = 0.02) and in the vehicle treated control group (P = 342 
0.004 & P = 0.05) ewes.  In longitudinal smooth muscle intra-cervical LH increased the 343 
expression of COX2 mRNA compared to both untreated control (P = 0.001) and vehicle treated 344 
control (P = 0.006) groups. However COX2 was increased compared to untreated controls (P = 345 
0.04) but not when compared to vehicle treated control (P = 0.10).  In transverse smooth muscle 346 
intra-cervical LH increased the expression of COX2 mRNA or compared to untreated control (P 347 
= 0.03) and vehicle treated control (P = 0.006) groups but it did not increase COX2 mRNA 348 
compared to untreated controls (P = 0.18) and vehicle treated controls (P = 0.22).  349 
 350 
Effects of FSH and LH on the Concentration of Hyaluronan in Cervical Tissue 351 
The concentrations of HA in the cervix are presented in Table 2.  The concentration of HA 352 
differed among cervical regions (P = 0.002) but not among treatments (P = 0.880).  There was 353 
significantly more HA in the vaginal end of the cervix compared to the uterine end (P < 0.003). 354 
There was no difference between the mid-cervix and the uterine end (P = 0.554) or the vaginal 355 
end and the mid-cervix (P = 0.078).  The interaction between treatment and region was not 356 
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significant (P = 0.194).  The water content of the cervix expressed as a percentage of the tissue 357 
wet weight was not affected by intra-cervical treatment with either FSH or LH (Table 3) but the 358 
water content of the cervix was slightly, but significantly (P = 0.002) lower at the vaginal end 359 
compared to the uterine end of the cervix (Table 3).  360 
 361 
Effects of FSH and LH on the Concentration of Hyaluronan in Cervical Mucus 362 
The concentration of HA in cervical mucus collected at 48 h and 54 h after the removal of 363 
progestagen pessary are presented in Figure 6.  The concentration of HA in mucus collected at 364 
48 h did not significantly differ among the treatments.  The concentration of HA in mucus 365 
collected at 54 h did not significantly differ among the treatments. The FSH group tended to 366 
have a lower HA concentration than the control group (P = 0.080). However, the significant 367 
interaction (P = 0.013) between treatment and time of mucus collection indicated that the 368 
concentration of HA at the different times was affected by treatment in different ways. Further 369 
investigation revealed that the concentration of HA in cervical mucus for the FSH-treated group 370 
was significantly lower at 54 h than at than 48 h (P < 0.014) whereas it was not affected by time 371 
in the other groups.  372 
 373 
 374 
Discussion 375 
In this study, the expression of COX2 and its mRNA was determined using semi quantitative 376 
methods (in situ hybridization for mRNA and immunohistochemistry for protein).  For both 377 
analyses a scoring system that had been previously validated, was used [10, 27, 28, 33].  378 
Furthermore, this system of quantification was able to describe the localization and distribution 379 
of expression at a cellular level.  Using these techniques, our study confirmed that both COX2 380 
and its mRNA are present in the cervix of the ewe during the follicular phase of the oestrous 381 
cycle [10, 27, 34]. Furthermore the results also show that the levels of COX2 and its RNA in the 382 
cervix can be altered by intra-cervical FSH or LH suggesting that the gonadotrophins may have a 383 
physiological role in the cervix of the oestrous ewe.  The dose of 2mg of LH or FSH was used 384 
for intra-cervical administration in this study and was based on our previous work where it was 385 
able to stimulate both the protein and mRNA expression of receptors for LH and FSH in the 386 
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cervical tissues of ewes  (Leethongdee et al., 2007a). Both of the receptors were expressed in all 387 
tissue layers of the cervix except the external serosa with the highest concentrations in the 388 
luminal epithelium and the irregular smooth muscle.  Moreover, cervical administration of 2 mg 389 
of FSH  was able to enhance the cervical relaxation in ewes (Leethongdee et al., 2007b, 2010). 390 
 391 
Both COX2 and its mRNA were detected in all cervical layers except the outer serosal layer. The 392 
level of expression of both COX2 and its mRNA was lower in the sub-epithelial stroma and 393 
higher in the luminal epithelium and the three layers of smooth muscle (Figure 4). In an earlier 394 
publication [27] the levels of COX2 mRNA were lowest in luminal epithelium and lower than 395 
the level of expression we observed in this study (Figure 4). The most likely explanation is that 396 
in the former study the cervices that were collected had not been manipulated at all whereas in 397 
this study a speculum had been inserted into the vagina at the time of treatment and also at 48 398 
and 54 hours later in order to collect cervical mucus.  While this discrepancy between the two 399 
studies regarding the levels of COX2 and its mRNA’s expression in the cervical layers 400 
(particularly luminal epithelium and sub-epithelial stroma) could be attributed to the 401 
manipulation in the form of insertion of vaginal speculum, this should not confound with the 402 
effects of intra-cervical treatments as the process of vaginal speculum insertion was similar for 403 
all the experimental groups including the vehicle and non-vehicle controls.  404 
 405 
The tissues of the cervix synthesize PGE2 from arachidonic acid (AA). The first step is the 406 
formation of prostaglandin H2 (PGH2) a reaction catalyzed by the COX enzyme.  The PGH2 is 407 
then converted to PGE2 by the enzyme PGES. The prostaglandin system is controlled mainly by 408 
COX [35] and because of the rapid catalytic inactivation of COX, this enzyme is the rate-limiting 409 
step in the synthesis of prostaglandins [36] in the cervix.  The various reproductive hormones act 410 
at multiple levels along the pathway of biosynthesis of PGE2. In vitro, oestradiol increased the 411 
cervical level of the oxytocin receptor, the level of COX2 and the concentration of PGE2 [18]. 412 
Furthermore the levels of OTR, oestradiol receptor α (ERα), cPLA2 and COX2 were all 413 
increased in the follicular phase of the oestrous cycle compared to the luteal phase [34, 40]. In 414 
addition, both FSH and LH have been implicated [7, 8, 19, 39] in cervical PG synthesis. Both 415 
FSH and LH receptors are present in the cervix of the ewe [10] cow [7, 8] and human [26, 41] 416 
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and the level of FSH receptor in the bovine cervix was at its maximum during the follicular 417 
phase [8]. In the ewe FSH has been shown to stimulate COX2 in an in vitro study [18] and in the 418 
present study the intra-cervical application of FSH or LH increased cervical COX2 mRNA and 419 
protein in the cervix of the non-pregnant ewe during the peri-ovulatory period (Figure 1). In the 420 
cow the production of PGE2 by cultured cervical tissue was induced by FSH [8]. The in vitro 421 
administration of both LH and FSH to cultures of cervical tissue from oestrous cows [8, 25] 422 
stimulated both the cAMP and inositol phosphate signaling pathways [8, 42] suggesting that FSH 423 
regulates the synthesis of cervical PGE2 through one or both of these pathways [8]. 424 
 425 
In this study, although COX2 was present in epithelium, stroma and smooth muscle indicating 426 
that they are all capable of synthesizing prostaglandins, the effects of intra-cervical FSH or LH 427 
differed.   Despite the presence of COX2 in luminal epithelium this tissue did not respond to 428 
intra-cervical FSH or LH whereas stroma responded only to FSH, increasing the levels of COX2 429 
and its mRNA while smooth muscle responded to both FSH and LH with increased levels of 430 
COX2 and its mRNA.  In the non-pregnant rat, COX2 was also localized to cervical smooth 431 
muscle, sub-epithelial stroma and epithelium as well as vascular smooth muscle [43] and COX2 432 
has also been detected in the human cervix [44] and human cervical fibroblasts [45].  433 
 434 
The cervix was analyzed in thirds; the uterine end, the mid-cervix and the vaginal end and the 435 
patterns of expression across these regions show that the level expression of COX2 was constant 436 
across the three regions but that the expression of COX2 mRNA was lower at the uterine end of 437 
the cervix (Figure 2). These finding are broadly in agreement with previous reports showing that 438 
levels of COX2 mRNA [10, 12, 27] and COX2 protein [34] were higher at the vaginal end of the 439 
cervix.  Along its length, the structure of the cervix is not uniform. There is a concentration of 440 
cervical folds at the vaginal end [2] which effectively obstructs the cervical canal while at the 441 
uterine end the cervical canal is quite open. Consequently there is a greater need for cervical 442 
remodeling at the vaginal end of the cervix and probably explains why the levels of COX2 are 443 
higher at the vaginal end of the cervix.  444 
 445 
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The non-cellular component of the cervix is composed of an extensive extra cellular matrix 446 
(ECM) that includes collagen, elastin and proteoglycans [46, 47]. The predominant GAG in the 447 
cervix of the non-pregnant ewe is hyaluronan-like accounting for 84 to 90% of total GAGs [5].  448 
In the present study, we determined the concentration of HA in cervical tissue and there was no 449 
effect of either FSH or LH although the concentration of HA was highest at the vaginal end of 450 
the cervix.  This finding mirrors the collagen content in the cervix of the non-pregnant cow 451 
where the highest collagen content was in the vaginal region and lowest in the uterine region 452 
[49]. These data show that there are regional differences of HA concentrations and that HA may 453 
influence the patterns of firmness along the longitudinal axes of the cervix and at different stages 454 
of the oestrous cycle. 455 
 456 
 457 
We determined the HA concentration in cervical mucus collected at 48 h and 54 h after pessary 458 
removal (Figure 6).  The concentration of HA in cervical mucus rose in the LH-treated group but 459 
not in the FSH-treated group. The high affinity of HA for water results in a thin watery mucus 460 
when HA concentrations in cervical mucus are increased leading to the secretion of a clear 461 
mucus during the peri-ovulatory period that facilitates the transport of spermatozoa through the 462 
cervix.   These data suggest that the intra-cervical application of FSH may be deleterious to the 463 
transport of spermatozoa through the cervix.   464 
 465 
The cervix of the ewe relaxes at oestrus a process that is similar to the mechanism of cervical 466 
ripening that occurs at parturition. Central to both cervical relaxation and cervical ripening is the 467 
local production of PGE2 and its control by reproductive hormones. Although the pattern of 468 
reproductive hormones at oestrus and parturition in some ways similar they are not identical and 469 
therefore it would be reasonable to assume that the mechanisms of cervical relaxation at oestrus 470 
and cervical ripening at parturition are also similar but not identical.  Relaxation of the cervix is 471 
due to a complex combination of biochemical and structural changes affecting the cervical 472 
connective tissue and leading to an extensible organ [56] and mediated by PGE2. The mechanism 473 
of action of PGE2 in the cervix appears to be multifaceted.  Receptors for PGE2 are present in 474 
luminal epithelium, stroma and smooth muscle [57]; and prostaglandin-mediated cervical 475 
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softening in sheep, probably involves PGE2 induced loosening of collagen bundles within the 476 
cervical ECM and increased production of HA [22, 53].  Hyaluronan in the ECM, because of its 477 
hydrophilic properties, draws water into the ECM leading to an increase in the relative 478 
proportion of collagen to smooth muscle in the wall of the cervix.   Cervical relaxation is 479 
affected by other mechanisms including increased collagenase activity [58] and local 480 
inflammatory reactions within cervical fibroblasts [59, 60]. However the predominate anatomical 481 
and physiological change in cervical ripening is rearrangement of collagen [61]. These effects 482 
result in a more pliable cervix. 483 
 484 
The patterns of contractility of smooth muscle in the cervical wall will also be altered by PGE2 485 
depending on the dominant receptor sub-types. Of the four prostaglandin E receptors (EP1 to 4), 486 
EP1 and EP3 increase the contractility of gastrointestinal smooth muscle while EP2 and EP4 487 
relax gastrointestinal smooth muscle [36]. We suggest that the effects of PGE2 on the smooth 488 
muscle of a more pliable cervix lead to cervical relaxation and an opening of the cervical canal at 489 
oestrus. 490 
 491 
There can be little doubt that a central player in cervical relaxation at oestrus is the local 492 
production of PGE2. In this study we have examined two aspects of PGE2 in the cervix, first the 493 
effect of FSH and LH on its synthesis by measuring the activity of COX2 in cervical tissue and 494 
second the action of PGE2 by measuring the effect of FSH and LH on HA. The main findings 495 
summarized in Table 4, are that FSH and LH both stimulated COX2 but neither had any effect 496 
on the concentration of cervical HA although FSH inhibited the concentration HA in cervical 497 
mucus late in the follicular phase.   This lack of FSH or LH effect on cervical HA cannot, 498 
however, be attributed to the relatively lower number of animals belonging to only one breed of 499 
sheep in the experimental groups as the variation observed in the data was not huge but normal.  500 
FSH stimulated COX2 in the stroma and all layers of smooth muscle while LH was effective 501 
only in circular smooth muscle. Neither FSH nor LH stimulated COX2 in luminal epithelium.  502 
We interpret these findings to suggest that FSH and LH have a role in cervical relaxation at 503 
oestrus in the ewe but on their own, they cannot induce full cervical relaxation.  It would appear 504 
that the role of FSH and LH is secondary to a primary role for oxytocin and oestradiol. 505 
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Table 1: The Mean±SEM body weight, body condition score, age, parity and reproductive 706 
history of ewes used in different experimental groups treated during the peri- ovulatory period. 707 
Treatment Number Weight 
(Kg) 
BCS 
(1-5) 
Age 
(Months) 
parity Reproductive 
history 
FSH  5 
37.4 
±3.7 2.8±0.3 19.6±2.1 
Multiparous cycling in last 
breeding season, 
Healthy 
LH  5 
37.4±3.5 3.0±0.4 19.2±2.3 
Nulliparous cycling in last 
breeding season, 
Healthy 
Gum acacia 
vehicle  
4 
35.8±1.7 3.1±0.3 20.2±1.5 
Nulliparous cycling in last 
breeding season, 
Healthy 
None (no 
vehicle) 
4 
36.8±3.1 2.8±0.5 20.7±2.9 
Nulliparous cycling in last  
breeding season, 
Healthy 
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Table 2:  The effect of intra-cervical FSH (n=5) or LH (n=5) on the concentration of hyaluronan 710 
(mean ± the standard error of the mean) in ovine cervical tissue collected during an induced 711 
follicular phase 54 hours after the removal of progestagen impregnated pessaries.  Control ewes 712 
were untreated (None; n=4) or treated with the gum acacia vehicle (Vehicle; n=4).  There were 713 
no significant differences. 714 
 715 
Treatment Hyaluronan (μg/mg wet weight) 
Uterine end Mid-cervix Vaginal end Total 
FSH 1.53 ± 0.18 1.34 ± 0.17 1.66 ± 0.17 1.51 ± 0.22 
LH 1.52 ± 017 1.63 ± 0.17 1.73 ± 0.17 1.63 ± 0.40 
Vehicle 1.31 ± 0.19 1.65 ± 0.19 1.78 ± 0.19 1.58 ± 0.52 
None 1.21 ± 0.19 1.61 ± 0.19 2.09 ± 0.19 1.64 ± 0.19 
Combined 1.41 ± 0.09a 1.55 ± 0.09a,b 1.80 ± 0.09b 1.59 ± 0.09 
 716 
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Table 3:  The effect of intra-cervical FSH (n=5) or LH (n=5) on the percentage content of water 718 
(mean ± the standard error of the mean) in ovine cervical tissue collected during an induced 719 
follicular phase 54 hours after the removal of progestagen impregnated pessaries.  Control ewes 720 
were untreated (None; n=4) or treated with the gum acacia vehicle (Vehicle; n=4).  Values with 721 
different superscripts are significantly different at the 5% level. 722 
 723 
 Water content (%)  
Treatment Uterine end Mid-cervix Vaginal end Whole cervix  
FSH 79.8 ± 0.41  78.2 ± 0.41  78.8 ± 0.41  78.9 ± 0.39a 
LH 78.9 ± 0.41  78.4 ± 0.41  78.7 ± 0.41  78.7 ± 0.28a 
Vehicle 79.2 ± 0.46  79.4 ± 0.46  77.2 ±0 .46  78.6 ± 0.31a 
None 78.8 ± 0.46  78.0 ± 0.46  77.1 ± 0.46  78.0 ± 0.38a 
Combined  79.2 ± 0.22x 78.5 ± 0.25x,y 78.0 ± 0.39y 78.6 ± 0.18 
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Table 4:  A summary of the effects of intra-cervical FSH or LH, on the expression of COX2, it’s 725 
mRNA and the concentration of HA in the cervix of the ewe during the follicular phase of the 726 
oestrous cycle.   An effect of either FSH or LH was only accepted if the treatment differed 727 
significantly from BOTH the untreated and vehicle control groups. 728 
 729 
Treatment 
COX2 
mRNA Protein 
FSH 
Selective stimulation of COX2 mRNA 
in the cervix. Stimulated expression 
only at the vaginal end of the cervix and 
in all cell layers except the luminal 
epithelium.  
 
Selective stimulation of COX2 in the 
cervix.  Stimulated expression at the 
uterine and vaginal ends of the cervix and 
in all cell layers except the luminal 
epithelium. 
LH 
Selective stimulation of COX2 mRNA 
in the cervix. Stimulated expression 
only at the vaginal end of the cervix and 
in the three muscle layers but not in the 
luminal epithelium or stroma. 
 
Selective stimulation of COX2 in the 
cervix.  Stimulated expression only at the 
vaginal end of the cervix but only in 
circular smooth muscle. 
 730 
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Figure legends 732 
 733 
Figure 1:  The effect of intra-cervical FSH (n=5) or LH (n=5) on the level of cervical expression 734 
(mean ± the standard error of the mean) of COX2 mRNA and COX2 in ovine cervical tissue 735 
collected during an induced follicular phase 54 hours after the removal of progestagen 736 
impregnated pessaries.  Control ewes were untreated (None; n=4) or treated with the gum acacia 737 
vehicle (Vehicle; n=4).  Columns with different letters differ significantly at P<005. Within 738 
treatments, columns with different superscripts are significantly different. 739 
 740 
Figure 2:  The level of cervical expression (mean ± the standard error of the mean) of COX2 741 
mRNA and COX2 in three regions of the ovine cervix (the uterine end, the mid-cervix and the 742 
vaginal end of the cervix).  Cervical tissue was collected during an induced follicular phase 54 743 
hours after the removal of progestagen impregnated pessaries.  Columns with different letters 744 
differ significantly at P<005.  Within regions of the cervix, columns with different superscripts 745 
are significantly different. 746 
 747 
Figure 3:  The effect of intra-cervical FSH (n=5; pale grey columns) or LH (n=5; medium grey 748 
columns) on the level of cervical expression (mean ± the standard error of the mean) of COX2 749 
mRNA and COX2 in three regions of the ovine cervix (the uterine end, the mid-cervix and the 750 
vaginal end of the cervix).  Cervical tissue was collected during an induced follicular phase 54 751 
hours after the removal of progestagen impregnated pessaries.  Control ewes treated with the 752 
gum acacia vehicle (Vehicle; n=4; dark grey columns) or were untreated (None; n=4; black 753 
columns). Columns with different letters differ significantly at P<005.  Within and regions of the 754 
cervix, columns with different superscripts are significantly different. 755 
 756 
Figure 4:  The level of cervical expression (mean ± the standard error of the mean) of COX2 757 
mRNA and COX2 in five cellular tissue layers of the ovine cervix.  The cellular layers are shown 758 
in order from the central lumen of the cervix (luminal epithelium, sub-epithelial stroma, 759 
longitudinal smooth muscle, circular smooth muscle and transverse smooth muscle).  Cervical 760 
tissue was collected during an induced follicular phase 54 hours after the removal of progestagen 761 
30 
 
impregnated pessaries.  Columns with different letters differ significantly at P<005.  Within 762 
cellular tissue layers of the cervix, columns with different superscripts are significantly different. 763 
 764 
Figure 5:  The effect of intra-cervical FSH (n=5; pale grey columns) or LH (n=5; medium grey 765 
columns) FSH (n=5) or LH (n=5) on the level of cervical expression (mean ± the standard error 766 
of the mean) of COX2 mRNA and COX2 in five cellular tissue layers of the ovine cervix.  The 767 
cellular layers are shown in order from the central lumen of the cervix (luminal epithelium, sub-768 
epithelial stroma, longitudinal smooth muscle, circular smooth muscle and transverse smooth 769 
muscle).  Cervical tissue was collected during an induced follicular phase 54 hours after the 770 
removal of progestagen impregnated pessaries.  Control ewes treated with the gum acacia vehicle 771 
(Vehicle; n=4; dark grey columns) or were untreated (None; n=4; black columns).  Columns with 772 
different letters differ significantly at P<005.  NB:  The asterisk (*) indicates a P value (P = 773 
0.055) approaching significance.  774 
 775 
Figure 6:  The effect of intra-cervical FSH (n=5) or LH (n=5) on the concentration of 776 
hyaluronan in cervical mucus collected during an induced follicular at 48 and 54 hours the 777 
removal of progestagen impregnated pessaries.  Control ewes were untreated (None; n=4) or 778 
treated with the gum acacia vehicle (Vehicle; n=4).  There were no significant differences. 779 
780 
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